Marshall S. Stanton - 20 Nov 2025 Form 4 Insider Report for ARTIVION, INC. (AORT)

Role
SVP, Clinical & MD Affair
Signature
/s/ Marshall Stanton
Issuer symbol
AORT
Transactions as of
20 Nov 2025
Net transactions value
-$622,391
Form type
4
Filing time
24 Nov 2025, 09:35:59 UTC
Previous filing
14 Nov 2025
Next filing
24 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stanton Marshall S. SVP, Clinical & MD Affair 1655 ROBERTS BLVD., NW, KENNESAW /s/ Marshall Stanton 24 Nov 2025 0001849615

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AORT Common Stock Sale $524,736 -11,888 -21% $44.14 44,753 20 Nov 2025 Direct F1
transaction AORT Common Stock Options Exercise $37,489 +2,033 +4.5% $18.44 46,786 20 Nov 2025 Direct
transaction AORT Common Stock Sale $90,092 -2,033 -4.3% $44.32 44,753 20 Nov 2025 Direct F2
transaction AORT Common Stock Options Exercise $14,946 +1,355 +3% $11.03 46,108 20 Nov 2025 Direct
transaction AORT Common Stock Sale $59,997 -1,355 -2.9% $44.28 44,753 20 Nov 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AORT Stock Options (Right to buy) Options Exercise $0 -2,033 -9.1% $0.000000 20,301 20 Nov 2025 Common Stock 2,033 $18.44 Direct F4
transaction AORT Stock Options (Right to buy) Options Exercise $0 -1,355 -4.8% $0.000000 27,075 20 Nov 2025 Common Stock 1,355 $11.03 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects weighted average price. Range of prices were between $43.92 to $44.49. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Reflects weighted average price. Range of prices were between $44.26 to $44.44. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Reflects weighted average price. Range of prices were between $44.26 to $44.35. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 23, 2023.
F5 Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.